Literature DB >> 17092433

CD44 and hematologic malignancies.

Jianing Liu1, Guosheng Jiang.   

Abstract

The expression of CD44 was upregulated in some hematological malignancies and is associated with metastasis and prognosis. The ligation of CD44 with specific monoclonal antibodies can trigger terminal differentiation of leukemic blasts in some subtypes, so it is probable to develop an anti-CD44 based differentiation therapy in leukemia. The effects of CD44 and its monoclonal antibodies are discussed in this review.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17092433

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


  32 in total

1.  In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker.

Authors:  Nidaa Ababneh; Walhan Alshaer; Omar Allozi; Azmi Mahafzah; Mohammed El-Khateeb; Hervé Hillaireau; Magali Noiray; Elias Fattal; Said Ismail
Journal:  Nucleic Acid Ther       Date:  2013-10-30       Impact factor: 5.486

2.  Arachidonate 12-lipoxygenase may serve as a potential marker and therapeutic target for prostate cancer stem cells.

Authors:  Bo Yin; Yang Yang; Zhiqiang Zhao; Yu Zeng; Steven M Mooney; Ming Li; Xuewen Xu; Yongsheng Song; Bin Wu; Zhibo Yang
Journal:  Int J Oncol       Date:  2011-01-11       Impact factor: 5.650

3.  CD44 is a marker for the outer pillar cells in the early postnatal mouse inner ear.

Authors:  Ronna Hertzano; Chandrakala Puligilla; Siaw-Lin Chan; Caroline Timothy; Didier A Depireux; Zubair Ahmed; Jeffrey Wolf; David J Eisenman; Thomas B Friedman; Sheikh Riazuddin; Matthew W Kelley; Scott E Strome
Journal:  J Assoc Res Otolaryngol       Date:  2010-04-13

4.  Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma.

Authors:  Lkhagva-Ochir Tovuu; Satoru Imura; Tohru Utsunomiya; Yuji Morine; Tetsuya Ikemoto; Yusuke Arakawa; Hiroki Mori; Jun Hanaoka; Mami Kanamoto; Koji Sugimoto; Shuichi Iwahashi; Yu Saito; Shinichiro Yamada; Michihito Asanoma; Hidenori Miyake; Mitsuo Shimada
Journal:  Int J Clin Oncol       Date:  2012-06-16       Impact factor: 3.402

5.  Epigenetic deregulation in pediatric acute lymphoblastic leukemia.

Authors:  Zac Chatterton; Leah Morenos; Francoise Mechinaud; David M Ashley; Jeffrey M Craig; Alexandra Sexton-Oates; Minhee S Halemba; Mandy Parkinson-Bates; Jane Ng; Debra Morrison; William L Carroll; Richard Saffery; Nicholas C Wong
Journal:  Epigenetics       Date:  2014-01-06       Impact factor: 4.528

Review 6.  Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?

Authors:  Anine M Crous; Heidi Abrahamse
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832

Review 7.  Cancer stem cells: Regulation programs, immunological properties and immunotherapy.

Authors:  Dingxiao Zhang; Dean G Tang; Kiera Rycaj
Journal:  Semin Cancer Biol       Date:  2018-05-09       Impact factor: 15.707

8.  CD44 microbeads accelerate HIV-1 infection in T cells.

Authors:  Valeri H Terry; Ian C D Johnston; Celsa A Spina
Journal:  Virology       Date:  2009-04-23       Impact factor: 3.616

Review 9.  Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.

Authors:  Bryan P Toole; Mark G Slomiany
Journal:  Drug Resist Updat       Date:  2008-05-19       Impact factor: 18.500

10.  Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice.

Authors:  Guangchun Jin; Vigneshwaran Ramanathan; Michael Quante; Gwang Ho Baik; Xiangdong Yang; Sophie S W Wang; Shuiping Tu; Shanisha A K Gordon; David Mark Pritchard; Andrea Varro; Arthur Shulkes; Timothy C Wang
Journal:  J Clin Invest       Date:  2009-08-03       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.